Herpes virus infections
Clinical information
The family of herpesviruses encompasses more than 100 different virus types, eight of which can cause infections in humans. These so-called human herpesviruses encompass herpes simplex virus of type 1 and 2 (HSV-1 and -2), varicella zoster virus (VZV), Epstein-Barr virus (EBV), cytomegalovirus (CMV), human herpesviruses 6 and 7 (HHV-6 and -7) as well as human herpesvirus 8 (HHV-8), which is associated with Kaposi sarcoma. Despite great structural similarities of the different pathogens, herpesvirus infection can cause very different diseases, e.g. cold sores or genital herpes, chickenpox, shingles, kissing disease or different cancers. During pregnancy, especially primary infection with particular herpesviruses may lead to severe damage or even loss of the child. There is currently only a vaccine against VZV. After primary infection, which often proceeds asymptomatically, herpesviruses persist life-long in the body in a latent state and may become reactivated at a later time point, e.g. due to a weakened immune system, and (again) cause symptoms.
Diagnostics
Laboratory diagnostics of herpesviruses is based on direct or indirect detection methods. Direct methods, which are especially relevant for diagnostics of acute infections or in immunosuppressed persons include, e.g. virus culture or PCR-based tests, in which viral nucleic acids are detected. Blister liquid, skin or mucosal smears, blood, CSF or broncoalveolar lavage fluid is used as sample material. If the herpesvirus specific antibody is detected in patient serum, plasma or CSF, this is considered as indirect pathogen detection. The antibody detection not only allows conclusions to be drawn on which virus is present in the patient, but can also contribute to the differentiation of primary and recurrent infections. EUROIMMUN offers a broad spectrum of products for the detection of herpesvirus infections, including both antibody detection and direct detection methods.
Selected Products
Method | Parameter | Substrate | Species | |
---|---|---|---|---|
PCR | EURORealTime HSV-1/2 | Details | ||
EUROArray | EUROArray HSV1/2 VZV | Details | ||
ChLIA | Control set Herpes simplex virus 1 (HSV-1) | Details | ||
WESTERNBLOT | antibodies against Herpes simplex virus (HSV) IgG positive control | Details | ||
ChLIA | Herpes simplex virus 1 (HSV-1) | Details | ||
ELISA | CSQ pair of controls anti-HSV-1/2 Pool (IgG) | Details | ||
WESTERNBLOT | EUROLINE-WB Herpes simplex virus 1 (HSV-1) plus HSV-2 type-specific glycoprotein G2 | Westernblot | Details | |
ELISA | Herpes simplex virus (HSV-1/2 Pool) | antigen-coated microplate wells | Details | |
ELISA | Herpes simplex virus (HSV-1/2 Pool) antibody determination in CSF | antigen-coated microplate wells | Details | |
ELISA | Herpes simplex virus (HSV-1/2 Pool) incl. IgG/RF absorbent | antigen-coated microplate wells | Details | |
ELISA | Herpes simplex virus 1 (HSV-1) | antigen-coated microplate wells | Details | |
ChLIA | Herpes simplex virus 2 (HSV-2) | Details | ||
ChLIA | Control set Herpes simplex virus 2 (HSV-2) | Details | ||
ELISA | Herpes simplex virus 2 (HSV-2) | antigen-coated microplate wells | Details | |
IIFT | HHV-6 | infected cells | EU 30 | Details |
IIFT | HHV-6 EUROPattern | infected cells | EU 30 | Details |
ELISA | Cytomegalovirus (CMV) | antigen-coated microplate wells | Details | |
ELISA | Cytomegalovirus (CMV) incl. IgG/RF absorbent | antigen-coated microplate wells | Details | |
ELISA | Cytomegalovirus (CMV) avidity determination | antigen-coated microplate wells | Details | |
ELISA | Cytomegalovirus (CMV) p52 incl. IgG/RF absorbent | antigen-coated microplate wells | Details | |
ELISA | Cytomegalovirus (CMV) gB | antigen-coated microplate wells | Details | |
ELISA | CSQ pair of controls anti-Cytomegalovirus (IgG) | Details | ||
ELISA | Cytomegalovirus (CMV) antibody determination in CSF | antigen-coated microplate wells | Details | |
ELISA | Varicella zoster virus (VZV) | antigen-coated microplate wells | Details | |
IIFT | Varicella zoster virus (VZV) | infected cells | EU 168 | Details |
ELISA | Varicella zoster virus (VZV) | antigen-coated microplate wells | Details | |
ELISA | Varicella zoster virus (VZV) incl. IgG/RF absorbent | antigen-coated microplate wells | Details | |
ELISA | Varicella zoster virus (VZV) avidity determination | antigen-coated microplate wells | Details | |
ELISA | Varicella zoster virus (VZV) avidity determination | antigen-coated microplate wells | Details | |
ELISA | Varicella zoster virus (VZV) glycoprotein incl. IgG/RF absorbent | antigen-coated microplate wells | Details | |
ELISA | CSQ pair of controls anti-VZV (IgG) | Details | ||
ELISA | Varicella zoster virus (VZV) antibody determination in CSF | antigen-coated microplate wells | Details | |
ELISA | Varicella zoster virus (VZV) antibody determination in CSF | antigen-coated microplate wells | Details | |
WESTERNBLOT | antibodies against Epstein-Barr virus (EBV) IgG positive control | Details | ||
WESTERNBLOT | antibodies against Epstein-Barr virus (EBV) IgM positive control | Details | ||
WESTERNBLOT | EUROLINE-WB Epstein Barr virus (EBV) | Details | ||
EUROLINE | positive control serum: IgG, human, 50x concentrated for EBV-Profil 2 G | Details | ||
EUROLINE | positive control serum: IgM, human, 50x concentrated for EBV-Profil 2 M | Details | ||
EUROLINE | EBV Profile 2 (VCA gp125, VCA p19, EBNA-1, p22, EA-D separately) | EUROLINE | Details | |
ChLIA | Epstein-Barr virus capsid antigen (EBV-CA) | Details | ||
ChLIA | Epstein-Barr virus capsid antigen (EBV-CA) | Details | ||
ChLIA | Control set Epstein-Barr virus capsid antigen (EBV-CA) | Details | ||
IIFT | Epstein-Barr virus capsid antigen (EBV-CA) | Details | ||
IIFT | expressing cells | P3HR1 | Details | |
IIFT | Epstein-Barr virus capsid antigen (EBV-CA) EUROPattern | expressing cells | P3HR1 | Details |
ELISA | Epstein-Barr virus capsid antigen (EBV-CA) | antigen-coated microplate wells | Details | |
ELISA | Epstein-Barr virus capsid antigen (EBV-CA) | antigen-coated microplate wells | Details | |
ELISA | Epstein-Barr virus capsid antigen (EBV-CA) incl. IgG/RF absorbent | antigen-coated microplate wells | Details | |
ELISA | Epstein-Barr virus capsid antigen (EBV-CA) avidity determination | antigen-coated microplate wells | Details | |
IIFT | EBV capsid antigen (EBV-CA) EBV early antigen (EBV-EA) | expressing cells (2 BIOCHIPs per field) | P3HR1 EU 33 | Details |
ELISA | CSQ pair of controls anti-EBV-CA (IgG) | Details | ||
ELISA | Epstein-Barr virus capsid antigen (EBV-CA) antibody determination in CSF | antigen-coated microplate wells | Details | |
ChLIA | Epstein-Barr virus nuclear antigen 1 (EBNA-1) | Details | ||
ChLIA | Control set Epstein-Barr virus nuclear antigen 1 (EBNA-1) | Details | ||
IIFT | Epstein-Barr virus nuclear antigen (EBNA) EUROPattern | expressing cells | Raji | Details |
IIFT | Epstein-Barr virus nuclear antigen (EBNA, complement-fixing antibodies) | expressing cells | Raji | Details |
ELISA | Epstein-Barr virus nuclear antigen (EBNA-1) | antigen-coated microplate wells | Details | |
IIFT | Epstein-Barr virus early antigen (EBV-EA) | expressing cells | EU 33 | Details |
IIFT | Epstein-Barr virus early antigen (EBV-EA) EUROPattern | expressing cells | EU 33 | Details |
ELISA | Epstein-Barr virus early antigen (EBV-EA) | antigen-coated microplate wells | Details | |
ELISA | Epstein-Barr virus early antigen (EBV-EA) | antigen-coated microplate wells | Details | |
ELISA | Epstein-Barr virus early antigen (EBV-EA) incl. IgG/RF absorbent | antigen-coated microplate wells | Details | |
IIFT | BIOCHIP Sequence EBV fields A and B: EBV-CA (IgG) field C: EBV-CA (IgM) field D: EBV-EA field E: EBNA | expressing cells expressing cells expressing cells expressing cells | P3HR1 P3HR1 EU 33 Raji | Details |
IIFT | EUROPLUS BIOCHIP Sequence EBV field A: EBV-CA (IgG), gp125 ag, p19 ag field B: EBV-CA (IgG) field C: EBV-CA (IgM), gp125 ag, p19 ag field D: EBV-EA field E: EBNA | expr. cells, gp125/p19/ ag-free BIOCHIP expressing cells expressing cells expr. cells, gp125/p19/ ag-free BIOCHIP expressing cells | P3HR1, native/rec. EU 120 P3HR1 P3HR1, native/rec. EU 120 EU 33 Raji | Details |